These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28754609)

  • 41. Oral nanomedicine approaches for the treatment of psychiatric illnesses.
    Dening TJ; Rao S; Thomas N; Prestidge CA
    J Control Release; 2016 Feb; 223():137-156. PubMed ID: 26739547
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Nanomedicine in otorhinolaryngology--future prospects].
    Dürr S; Tietze R; Lyer S; Alexiou C
    Laryngorhinootologie; 2012 Jan; 91(1):6-12. PubMed ID: 22231960
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nanomedicine strategies for drug delivery to the ear.
    Pritz CO; Dudás J; Rask-Andersen H; Schrott-Fischer A; Glueckert R
    Nanomedicine (Lond); 2013 Jul; 8(7):1155-72. PubMed ID: 23837855
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nanotheranostics and image-guided drug delivery: current concepts and future directions.
    Lammers T; Kiessling F; Hennink WE; Storm G
    Mol Pharm; 2010 Dec; 7(6):1899-912. PubMed ID: 20822168
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Finding the optimal balance: challenges of improving conventional cancer chemotherapy using suitable combinations with nano-sized drug delivery systems.
    Kratz F; Warnecke A
    J Control Release; 2012 Dec; 164(2):221-35. PubMed ID: 22705248
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nanoinformatics and DNA-based computing: catalyzing nanomedicine.
    Maojo V; Martin-Sanchez F; Kulikowski C; Rodriguez-Paton A; Fritts M
    Pediatr Res; 2010 May; 67(5):481-9. PubMed ID: 20118825
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Toward the emergence of nanoneurosurgery: part III--nanomedicine: targeted nanotherapy, nanosurgery, and progress toward the realization of nanoneurosurgery.
    Leary SP; Liu CY; Apuzzo ML
    Neurosurgery; 2006 Jun; 58(6):1009-26; discussion 1009-26. PubMed ID: 16723880
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nanoscale drug delivery for targeted chemotherapy.
    Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
    Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Advances in nanomedicines for malaria treatment.
    Aditya NP; Vathsala PG; Vieira V; Murthy RS; Souto EB
    Adv Colloid Interface Sci; 2013 Dec; 201-202():1-17. PubMed ID: 24192063
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic Applications of Curcumin Nanoformulations.
    Yallapu MM; Nagesh PK; Jaggi M; Chauhan SC
    AAPS J; 2015 Nov; 17(6):1341-56. PubMed ID: 26335307
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Can Bottom-Up Synthetic Biology Generate Advanced Drug-Delivery Systems?
    Lussier F; Staufer O; Platzman I; Spatz JP
    Trends Biotechnol; 2021 May; 39(5):445-459. PubMed ID: 32912650
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Emerging nanomedicine approaches fighting tumor metastasis: animal models, metastasis-targeted drug delivery, phototherapy, and immunotherapy.
    Liang C; Xu L; Song G; Liu Z
    Chem Soc Rev; 2016 Nov; 45(22):6250-6269. PubMed ID: 27333329
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protein-based nanomedicine platforms for drug delivery.
    Maham A; Tang Z; Wu H; Wang J; Lin Y
    Small; 2009 Aug; 5(15):1706-21. PubMed ID: 19572330
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calibration-quality cancer nanotherapeutics.
    Perry JL; Kai MP; Reuter KG; Bowerman C; Christopher Luft J; DeSimone JM
    Cancer Treat Res; 2015; 166():275-91. PubMed ID: 25895873
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nanomedicine for Treatment of Lung Cancer.
    Hussain S
    Adv Exp Med Biol; 2016; 890():137-47. PubMed ID: 26703803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern.
    Lam PL; Wong WY; Bian Z; Chui CH; Gambari R
    Nanomedicine (Lond); 2017 Feb; 12(4):357-385. PubMed ID: 28078952
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systems-level thinking for nanoparticle-mediated therapeutic delivery to neurological diseases.
    Curtis C; Zhang M; Liao R; Wood T; Nance E
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Mar; 9(2):. PubMed ID: 27562224
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Emerging Nano-Formulations and Nanomedicines Applications for Ocular Drug Delivery.
    Khiev D; Mohamed ZA; Vichare R; Paulson R; Bhatia S; Mohapatra S; Lobo GP; Valapala M; Kerur N; Passaglia CL; Mohapatra SS; Biswal MR
    Nanomaterials (Basel); 2021 Jan; 11(1):. PubMed ID: 33445545
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent Nano-based Therapeutic Intervention of Bioactive Sesquiterpenes: Prospects in Cancer Therapeutics.
    Ansari MA; Badrealam KF; Alam A; Tufail S; Khalique G; Equbal MJ; Alzohairy MA; Almatroudi A; Alomary MN; Pottoo FH
    Curr Pharm Des; 2020; 26(11):1138-1144. PubMed ID: 31951164
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of Tumor Microenvironment on the Distribution and Elimination of Nano-formulations.
    Chaurasiya B; Mahanty A; Roy D; Shen Y; Tu J; Sun C
    Curr Drug Metab; 2016; 17(8):783-798. PubMed ID: 27280439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.